Endo International Liabilities 2024

Endo International Aktienanalyse

What does Endo International do?

Endo International PLC is a global pharmaceutical company based in Ireland, specializing in the development, manufacturing, and distribution of prescription medications. The company was founded in New York City in 1920 as a small narcotic business and has since undergone significant changes and expansion through mergers and acquisitions. Endo now has its headquarters in Dublin, Ireland and a diverse portfolio of prescription drugs in various therapeutic areas. The company's business model focuses on the development and marketing of innovative and generic pharmaceuticals, medical devices, and diagnostic solutions to improve global patient health. It operates in five segments: Branded Pharmaceuticals, Generics, International Pharmaceuticals, Urology, and Specialty Products. The Branded Pharmaceuticals segment includes a wide range of prescription drugs targeting various indications, including pain relievers, hormone therapies, gastrointestinal products, and oncology treatments. Some of Endo's well-known brands include Lidoderm, Voltaren, and Percocet. The Generics division produces and distributes a variety of generic medications under different brand names, utilizing synergies within its network to reduce manufacturing costs and pass savings on to customers. The International Pharmaceuticals unit is responsible for Endo's global business, maintaining partnerships and joint ventures with partners worldwide and expanding the company's portfolio into new regions and markets. The Urology segment offers a broad spectrum of products and services for urology, including surgical and non-surgical procedures. This includes the globally top-selling transurethral resection generator, the GreenLight Laser. Endo's Specialty Products segment manufactures devices and active ingredients for critical infrastructure used in medical research and development. This unit has heavily focused on developing innovative solutions for medical challenges in recent years. Overall, Endo holds approximately 1% market share of the global pharmaceutical market. To strengthen its competitive position, the company focuses on expanding its product portfolio, increasing efficiency, and reducing costs. Endo has a strong presence in the American and European markets and is also active in emerging economies. It follows a growth strategy that emphasizes the introduction of new and innovative products to further expand its existing segments and explore new business areas. In 2020, Endo employed over 3500 employees worldwide and generated approximately $2.5 billion in revenue. The company aims to solidify its position as a leading pharmaceutical company and expand its influence in the global market. Endo International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Endo International's Liabilities

Endo International's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Endo International's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Endo International's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Endo International's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Endo International’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Endo International Stock

What is the level of liabilities of Endo International this year?

Endo International has a debt balance of 11.73 B USD this year.

What were the liabilities of Endo International compared to the previous year?

The liabilities of Endo International have increased by 18.29% increased compared to the previous year.

What are the consequences of high debt for investors of Endo International?

High liabilities can pose a risk for investors of Endo International, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Endo International?

Low liabilities mean that Endo International has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Endo International affect the company?

An increase in liabilities of Endo International can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Endo International affect the company?

A decrease in the liabilities of Endo International can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Endo International?

Some factors that can influence the liabilities of Endo International include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Endo International so important for investors?

The liabilities of Endo International are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Endo International take to modify the liabilities?

To change its liabilities, Endo International can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Endo International pay?

Over the past 12 months, Endo International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Endo International is expected to pay a dividend of 0 USD.

What is the dividend yield of Endo International?

The current dividend yield of Endo International is .

When does Endo International pay dividends?

Endo International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Endo International?

Endo International paid dividends every year for the past 0 years.

What is the dividend of Endo International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Endo International located?

Endo International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Endo International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Endo International from 7/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did Endo International pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of Endo International in the year 2023?

In the year 2023, Endo International distributed 0 USD as dividends.

In which currency does Endo International pay out the dividend?

The dividends of Endo International are distributed in USD.